E2F8 high expression is strongly associated with a worse outcome of GBM patients and radio-resistance while E2F8 knockdown decreased proliferation and tumor growth and inhibited invasion, migration and the expression of genes implicated in metastasis [49]. Here, E2F8 is linked to glioblastoma.